
Since 1930, Citrini found, the S&P 500 has fallen an average 1.1% in the last two weeks of September before bouncing back in October.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

Since 1930, Citrini found, the S&P 500 has fallen an average 1.1% in the last two weeks of September before bouncing back in October.

There is a correlation between increasing dividends and strong investment performance — even if a stock has a low dividend yield when you buy.

Playing an official part in the IPO process could give Robinhood more influence over the number of shares allocated to its customers.

Nvidia and Amazon Web Services are deepening their AI partnership with two million new GPUs, custom chips, and government AI factories.

Interest-rate strategists at Goldman Sachs Group Inc., Wells Fargo & Co. and other Wall Street firms said the US Treasury Department’s bond buybacks will do little to reverse the jump in long-term yields.

JPMorgan Chase & Co. and Morgan Stanley are among banks shareholders are suing over their roles on multibillion-dollar buyout deals after a recent corporate-law overhaul failed to protect financial advisers from potential liability.

LCN Capital Partners specializes in sale-leaseback transactions and manages about $3 billion in assets.

Even before Nvidia Corp.’s splashy $500 billion financing partnership this week, investors were starting to fret over the roughly $70 billion in phantom liabilities that don’t appear on major AI companies’ balance sheets, but could materialize at the worst possible time.

Anthropic PBC is telling prospective investors its second-quarter revenue jumped at least 14-fold versus the same period a year ago, according to documents seen by Bloomberg News.

Goldman Sachs Group will pay as much as $2.25 billion to buy Neos Investments, expanding its asset manager's reach in the actively managed ETF market. Katherine Doherty reports on "Bloomberg Open Interest."
(Bloomberg) -- Latigo Biotherapeutics Inc., a clinical-stage developer of non-opioid pain medicines, climbed 17% on Friday after raising $345.6 million in an upsized initial public offering, priced at the top of a marketed range.Most Read from BloombergOpenAI’s New Device Will Be Hockey Puck-Sized and Cost Over $300Iran Wants to Bar US, Israeli Ships From Hormuz in Peace AccordIran Says Agreement on Hormuz Shipping Reached With OmanTrump Administration Considers Order on Autism and VaccinesWhy D
Stock Market Today: The Dow Jones index rises, while tech futures drop as AI stocks Sandisk and Western Digital plunge on earnings.
(Bloomberg) -- The momentum trade just gave investors a taste of the pronounced profit-and-loss swings they can expect if they fail to hedge or diversify, a warning that’s reinforced by growing inflation risks. Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSaudi Prince Concerned Over Trump’s Iran Strike Plan: AxiosTrump Says Iran Talks to Begin Monday After Scrapping AttackSingapore's Gated Island for the Rich Is Marred by Decayed HomesAlibaba Adds to China AI Break
Financial stocks like XLF, JPMorgan, and Bank of America hit new highs on strong Q2 earnings as investors rotate out of technology, though bank shares pulled back ahead of the Fed meeting.
Financial stocks have been among the market’s best performers this month. The Fed’s next move, however, may determine how much further the rotation can run.
Robinhood Markets (Nasdaq: HOOD) reported its earnings for the second quarter of 2026 on July 29. The brokerage platform, popular for its equity, crypto, and tokenized stock offerings, generated $1.31 billion in revenue and $0.62 in earnings per share (EPS), beating Wall ...
(Bloomberg) -- Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, surged 67% on Friday after raising $128.7 million in an upsized initial public offering.Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump Rebuilds Tariffs With New Levies on 60 EconomiesSpaceX Turns Away Falcon Customers in Majo
President Donald Trump’s threat of 100% tariffs on generic drugs would seem to be a problem for Teva Pharmaceutical. It might not be.
(Bloomberg) -- One of the most enduring foreign-exchange bets is off to its best run in decades as surprisingly muted volatility across asset classes has investors piling into carry trades.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Campaign After Troo
(Bloomberg) -- Moonshot AI has told investors it’s preparing to list in as early as six months, seizing the opportunity to tap capital markets after its latest model upended industry perceptions of China’s burgeoning capabilities and sent global tech stocks reeling.Most Read from BloombergFCC Near Rulings Against Disney Over ‘The View,’ TV LicensesUS Strikes Iran to ‘Punish’ It for Attack That Killed 2 TroopsThousands of Trucks Haul Iraq’s Oil Through Syria in Sign of Hormuz LegacyTaylor Farms P
📈 Follow our live markets data and coverage. It was an epic quarter for investment banks. Goldman Sachs said this week that its stock-trading revenue hit a record $7.4 billion, up 72% from a year earlier.
Assets under supervision stood at $4.04tn as of 30 June, supported by $230bn of net inflows and $161bn of market appreciation.
Jamie Dimon said conditions were nearly ‘as good as it gets’ after JPMorgan reported a big jump in profit.
Goldman Sachs Group Inc (NYSE:GS, XETRA:GOS) shares rose more than 6% on Tuesday after the investment bank reported second quarter results that exceeded Wall Street expectations, driven by strong performances in investment banking and trading. For the quarter ended June 30, Goldman Sachs...
Investing.com -- Goldman Sachs Group Inc. (NYSE:GS) reported second-quarter earnings on Tuesday, exceeding analyst expectations, driven by strong performance in its trading and investment banking businesses.
The bank's equities unit brought in $7.42 billion, its third consecutive all-time record, while investment banking fees climbed 55%
Dow Jones banks JPMorgan Chase, Goldman Sachs detailed Q2 results on Tuesday. JPM stock slides away from a buy zone.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.